Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael J. Coyle currently holds 15,394 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Coyle has been a net seller of HAE stock. They have purchased $0 and sold $46.9M worth of shares.
Michael J. Coyle's most recent insider trade was on Jul 24, 2025, when they sold 2,693 shares at $0.00 per share.
Michael J. Coyle serves as Executive at HAEMONETICS CORP (HAE). They have executed 706 insider transactions totaling $46.9M over their tenure at the company.
Michael J. Coyle holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael J. Coyle has shown a selling trading pattern, with $0 in total purchases and $46.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael J. Coyle was on Aug 22, 2018, when they sold $13.9M worth of MDT shares. This transaction involved 145,544 shares at $95.50 per share.
Michael J. Coyle currently owns 15,394 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael J. Coyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael J. Coyle has 706 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Michael J. Coyle and 40,000+ other insiders.